Dyne Therapeutics, Inc.
DYN
DELAYED 1 MONTH

24 insider filings · Latest: Jul 27, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Mar 5, 2026Mar 6 9:08 PMJohn CoxDirector, CEO & President
Sale
2,732$14.90$40.7K374,145(D)

View →

← Previous

Page 2 of 2

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jun 5, 2026Jun 9 9:15 PMEdward HurwitzDirector
Grant/Award
35,152$17.0435,152(D)

View →

Jun 5, 2026Jun 9 9:13 PMDavid Charles LubnerDirector
Grant/Award
35,152$17.0435,152(D)

View →

Jun 5, 2026Jun 9 9:13 PMJason P RhodesDirector
Grant/Award
35,152$17.0435,152(D)

View →

Jun 5, 2026Jun 9 9:12 PMDirk KerstenDirector
Grant/Award
35,152$17.0435,152(D)

View →

Jun 5, 2026Jun 9 9:12 PMCarlo IncertiDirector
Grant/Award
35,152$17.0435,152(D)

View →

Jun 5, 2026Jun 9 9:09 PMCatherine Stehman-BreenDirector
Grant/Award
35,152$17.0435,152(D)

View →

Jun 5, 2026Jun 9 9:06 PMBrian S PosnerDirector
Grant/Award
35,152$17.0435,152(D)

View →